Vaxart Inc (VXRT)

Name: Vaxart Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$39.2M

Net Income

$5.2M

Operating Margin

13.2%

Free Cash Flow

$7.6M

Debt / Assets

52.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Vaxart Inc (VXRT).
Income Statement (Quarterly)	2026-03-31	2025-03-31	2024-12-31	2024-09-30
Revenue	39,227,000	20,876,000	15,185,000	4,933,000
Cost of Revenue	0	0	0	0
Gross Profit	39,227,000	20,876,000	15,185,000	4,933,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	4,641,000	5,067,000	4,023,000	4,342,000
Operating Expenses	34,054,000	35,811,000	26,677,000	19,408,000
Operating Income	5,173,000	-14,935,000	-11,492,000	-14,475,000
Interest Expense	505,000	997,000	924,000	631,000
Income Before Tax	5,208,000	-15,496,000	-11,809,000	-14,062,000
Income Tax Expense	29,000	95,000	176,000	18,000
Net Income	5,179,000	-15,591,000	-11,985,000	-14,080,000
Per Share
EPS	0.02	-0.07	-0.01	-0.01
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Vaxart Inc (VXRT).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	237,258,000	28,700,000	7,379,000	107,000	892,000
Cost of Revenue	0	0	0	3,267,000	0
Gross Profit	237,258,000	28,700,000	7,379,000	-3,160,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	17,608,000	20,780,000	22,584,000	29,386,000	21,890,000
Operating Expenses	219,184,000	94,993,000	90,726,000	110,440,000	70,639,000
Operating Income	18,074,000	-66,293,000	-83,347,000	-114,587,000	-72,752,000
Interest Expense	2,823,000	2,969,000	1,447,000	1,305,000	1,480,000
Income Before Tax	16,803,000	-66,688,000	-82,204,000	-107,691,000	-70,363,000
Income Tax Expense	476,000	260,000	261,000	67,000	107,000
Net Income	16,327,000	-66,948,000	-82,465,000	-107,758,000	-70,470,000
Per Share
EPS	0.07	-0.03	-0.06	-0.84	-0.58
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Vaxart Inc (VXRT).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	53,814,000	25,229,000	34,755,000	44,013,000
Short Term Investments	9,993,000	26,494,000	4,958,000	49,704,000
Net Receivables	51,345,000	11,969,000	3,008,000	20,000
Inventory	0	0	0	2,000,000
Total Current Assets	115,152,000	68,260,000	45,536,000	99,451,000
Property Plant Equipment	25,850,000	29,109,000	36,571,000	41,300,000
Goodwill and Intangibles	7,334,000	8,065,000	8,797,000	9,528,000
Total Assets	186,079,000	166,389,000	91,830,000	153,847,000
Liabilities
Account Payables	21,496,000	6,963,000	1,584,000	5,514,000
Short Term Debt	2,978,000	7,136,999	6,506,000	2,228,000
Total Current Liabilities	21,564,000	90,878,000	13,724,000	17,921,000
Long Term Debt	6,007,000	16,147,000	20,008,000	19,477,000
Total Liabilities	98,281,000	107,464,000	34,025,000	43,250,000
Shareholders Equity
Retained Earnings	-460,195,000	-476,522,000	-409,574,000	-327,109,000
Total Shareholders Equity	87,798,000	58,925,000	57,805,000	110,597,000

Balance sheet annual history for Vaxart Inc (VXRT).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	53,814,000	25,229,000	34,755,000	44,013,000	143,745,000
Short Term Investments	9,993,000	26,494,000	4,958,000	49,704,000	22,742,000
Net Receivables	51,345,000	11,969,000	3,008,000	20,000	71,000
Inventory	0	0	0	2,000,000	0
Total Current Assets	115,152,000	68,260,000	45,536,000	99,451,000	169,167,000
Property Plant Equipment	25,850,000	29,109,000	36,571,000	41,300,000	19,769,000
Goodwill and Intangibles	7,334,000	8,065,000	8,797,000	9,528,000	15,132,000
Total Assets	186,079,000	166,389,000	91,830,000	153,847,000	221,168,000
Liabilities
Account Payables	21,496,000	6,963,000	1,584,000	5,514,000	3,872,000
Short Term Debt	2,978,000	7,136,999	6,506,000	2,228,000	1,011,000
Total Current Liabilities	21,564,000	90,878,000	13,724,000	17,921,000	10,783,000
Long Term Debt	6,007,000	16,147,000	20,008,000	19,477,000	11,997,000
Total Liabilities	98,281,000	107,464,000	34,025,000	43,250,000	33,637,000
Shareholders Equity
Retained Earnings	-460,195,000	-476,522,000	-409,574,000	-327,109,000	-219,351,000
Total Shareholders Equity	87,798,000	58,925,000	57,805,000	110,597,000	187,531,000

Cash flow quarterly history for Vaxart Inc (VXRT).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	16,327,000	-66,948,000	-82,465,000	-107,758,000
Depreciation & Amortization	8,579,000	8,850,000	4,500,000	5,805,000
Stock Based Compensation	8,314,000	11,501,000	14,132,000	13,587,000
Change in Working Capital	0	3,262,000	-10,850,000	-4,698,000
Operating Cash Flow	7,714,000	-44,764,000	-70,453,000	-94,779,000
Investing Activities
Capital Expenditure	-145,000	-554,000	-1,871,000	-9,601,000
Investments	-145,000	-554,000	-1,871,000	-9,601,000
Investing Cash Flow	16,632,000	-21,324,000	43,952,000	-20,415,000
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	53,000	56,776,000	15,243,000	17,237,000
Dividends Paid	0	0	0	0
Financing Cash Flow	4,239,000	56,562,000	15,243,000	17,462,000
Summary
Free Cash Flow	7,569,000	-45,318,000	-72,324,000	-104,380,000
Net Change in Cash	28,585,000	-9,526,000	-11,258,000	-97,732,000

Cash flow annual history for Vaxart Inc (VXRT).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	16,327,000	-66,948,000	-82,465,000	-107,758,000	-70,470,000
Depreciation & Amortization	8,579,000	8,850,000	4,500,000	5,805,000	4,208,000
Stock Based Compensation	8,314,000	11,501,000	14,132,000	13,587,000	8,867,000
Change in Working Capital	0	3,262,000	-10,850,000	-4,698,000	-2,120,000
Operating Cash Flow	7,714,000	-44,764,000	-70,453,000	-94,779,000	-59,832,000
Investing Activities
Capital Expenditure	-145,000	-554,000	-1,871,000	-9,601,000	-5,157,000
Investments	-145,000	-554,000	-1,871,000	-9,601,000	-5,157,000
Investing Cash Flow	16,632,000	-21,324,000	43,952,000	-20,415,000	-49,097,000
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	53,000	56,776,000	15,243,000	17,237,000	122,210,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	4,239,000	56,562,000	15,243,000	17,462,000	125,804,000
Summary
Free Cash Flow	7,569,000	-45,318,000	-72,324,000	-104,380,000	-64,989,000
Net Change in Cash	28,585,000	-9,526,000	-11,258,000	-97,732,000	16,875,000